Behavioral Tolerance to Lysergic Acid Diethylamide is Associated with Reduced Serotonin-2A Receptor Signaling in Rat Cortex

被引:0
作者
Paul J Gresch
Randy L Smith
Robert J Barrett
Elaine Sanders-Bush
机构
[1] Vanderbilt University School of Medicine,Department of Pharmacology
[2] Vanderbilt University School of Medicine,Department of Psychiatry
[3] Veterans Administration Medical Center,undefined
来源
Neuropsychopharmacology | 2005年 / 30卷
关键词
tolerance; LSD; serotonin; hallucinogen; 5-HT; receptor; [; S]GTP; S autoradiography;
D O I
暂无
中图分类号
学科分类号
摘要
Tolerance is defined as a decrease in responsiveness to a drug after repeated administration. Tolerance to the behavioral effects of hallucinogens occurs in humans and animals. In this study, we used drug discrimination to establish a behavioral model of lysergic acid diethylamide (LSD) tolerance and examined whether tolerance to the stimulus properties of LSD is related to altered serotonin receptor signaling. Rats were trained to discriminate 60 μg/kg LSD from saline in a two-lever drug discrimination paradigm. Two groups of animals were assigned to either chronic saline treatment or chronic LSD treatment. For chronic treatment, rats from each group were injected once per day with either 130 μg/kg LSD or saline for 5 days. Rats were tested for their ability to discriminate either saline or 60 μg/kg LSD, 24 h after the last chronic injection. Rats receiving chronic LSD showed a 44% reduction in LSD lever selection, while rats receiving chronic vehicle showed no change in percent choice on the LSD lever. In another group of rats receiving the identical chronic LSD treatment, LSD-stimulated [35S]GTPγS binding, an index of G-protein coupling, was measured in the rat brain by autoradiography. After chronic LSD, a significant reduction in LSD-stimulated [35S]GTPγS binding was observed in the medial prefrontal cortex and anterior cingulate cortex. Furthermore, chronic LSD produced a significant reduction in 2,5-dimethoxy-4-iodoamphetamine-stimulated [35S]GTPγS binding in medial prefrontal cortex and anterior cingulate cortex, which was blocked by MDL 100907, a selective 5-HT2A receptor antagonist, but not SB206553, a 5-HT2C receptor antagonist, indicating a reduction in 5-HT2A receptor signaling. 125I-LSD binding to 5-HT2A receptors was reduced in cortical regions, demonstrating a reduction in 5-HT2A receptor density. Taken together, these results indicate that adaptive changes in LSD-stimulated serotonin receptor signaling may mediate tolerance to the discriminative stimulus effects of LSD.
引用
收藏
页码:1693 / 1702
页数:9
相关论文
共 125 条
[1]  
Adams LM(1985)A proposed animal model for hallucinogens based on LSD's effects on patterns of exploration in rats Behav Neurosci 99 881-900
[2]  
Geyer MA(2000) autoradiography of serotonin 5-HT(2A/2C) receptor-activated G protein: guanosine-5′-(gamma-[(35)S]thio)triphosphate binding in rat brain J Neurosci Res 61 674-685
[3]  
Adlersberg M(2000)Serotonin model of schizophrenia: emerging role of glutamate mechanisms Brain Res Brain Res Rev 31 302-312
[4]  
Arango V(1976)Drugs as the discriminative events in humans Psychopharmacol Commun 2 327-330
[5]  
Hsiung S(1990)Drug discrimination as a tool in drug abuse research Psychopharmacology 101 S65-701
[6]  
Mann JJ(2004)LSD, 5-HT (serotonin), and the evolution of a behavioral assay Neurosci Biobehav Rev 27 693-148
[7]  
Underwood MD(1990)Lysergic acid diethylamide (LSD) administration selectively downregulates serotonin2 receptors in rat brain Neuropsychopharmacology 3 137-870
[8]  
Liu K(1988)Differences in the stimulus properties of 3, 4-methylenedioxyamphetamine and 3, 4- methylenedioxymethamphetamine in animals trained to discriminate hallucinogens from saline J Pharmacol Exp Ther 246 866-54
[9]  
Aghajanian GK(1985)Behavioral and 5-HT antagonist effects of ritanserin: a pure and selective antagonist of LSD discrimination in rat Psychopharmacology 86 45-209
[10]  
Marek GJ(1999)Cellular and subcellular distribution of the serotonin 5-HT2A receptor in the central nervous system of adult rat J Comp Neurol 409 187-73